Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) are unsatisfactory, and
resistance to platinum
drugs is one of the important reasons. The
resistance of gliomas
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) and tumor surgery are limited by anticancer
drug resistance and tumor invasion. Evidence suggests
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) drug therapy for AF patients is often ineffective and may have adverse effects. Radiofrequency ablation
Gareev, Ilgiz,
Beylerli, Ozal,
Ahmad, Aamir,
Ilyasova, Tatiana,
Shi, Huaizhang,
Chekhonin, Vladimir (2024) evidence has implicated circRNAs in the pathogenesis of
multiple cardiovascular diseases, including
Wang, Chunlei,
Beylerli, Ozal,
Gu, Yan,
Xu, Shancai,
Ji, Zhiyong,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Chekhonin, Vladimir (2024) , prognosis, stratification of patients, forecasting tumor responses, and pinpointing new targets for
drugBeylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) . Emphasis is placed on the role of the BBB and BTB in modulating
drug delivery and therapeutic outcomes
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and
resistance to therapy. Modern
Zivari-Ghader, Tayebeh,
Valioglu, Ferzane,
Eftekhari, Aziz,
Aliyeva, Immi,
Beylerli, Ozal,
Davran, Soodabeh,
Cho, William C.,
Beilerli, Aferin,
Khalilov, Rovshan,
Javadov, Sabzali (2024) aggregation and thus help cure Alzheimer's disease.
Drug moieties can be effectively directed to the brain
Gareev, Ilgiz,
Beylerli, Ozal,
Yang, Guang,
Izmailov, Adel,
Shi, Huaizhang,
Sun, Jinxian,
Zhao, Boxian,
Liu, Binbing,
Zhao, Shiguang (2021) to Ago2 protein, which makes them
resistant to the effects of RNAse. Therefore, circulating mi
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) avenues for exploration. These ncRNAs exert influence over the prognosis and treatment
resistance of brain